Literature DB >> 9792628

Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.

J A Lawson1, H Li, J Rokach, M Adiyaman, S W Hwang, S P Khanapure, G A FitzGerald.   

Abstract

Isoprostanes (iPs) are nonenzymatic, free radical-derived compounds isomeric with enzymatically formed eicosanoids such as prostaglandins, leukotrienes, and thromboxanes. One group formed by the auto-oxidation of arachidonic acid, the F2-iPs, consists of four classes of isomers of prostaglandin F2alpha (PGF2alpha). They are relatively abundant in human urine. This fact, along with their chemical stability and excellent characteristics for quantitation by gas chromatography/mass spectrometry, has made them attractive indices of oxidative stress in humans. We developed a specific assay using gas chromatography/mass spectrometry for the first identified F2-iP, iPF2alpha-III (previously called 8-iso-PGF2alpha or 8-epi-PGF2alpha), which demonstrated the utility of monitoring a specific isomer. Recently, we described an assay for another isomer, iPF2alpha-VI, which is present in urine in greater concentration than iPF2alpha-III and which is particularly amenable to quantitation. We now describe the identification in human urine of two more isomers, 8,12-iso-iPF2alpha-VI and 5-epi-8, 12-iso-iPF2alpha-VI, using high performance liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. These compounds are each present in approximately 5-fold greater concentrations than iPF2alpha-VI (approximately 20-fold greater than iPF2alpha-III). They share the unique chemical characteristics of class VI compounds, which make them attractive targets for quantitation by gas chromatography/mass spectrometry and immunoassay development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792628     DOI: 10.1074/jbc.273.45.29295

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.

Authors:  C N Serhan; E Oliw
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup.

Authors:  Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski; Leslie M Shaw
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-07-01       Impact factor: 3.205

3.  Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice.

Authors:  Lihong Chen; Guangrui Yang; James Monslow; Leslie Todd; David P Cormode; Jun Tang; Gregory R Grant; Jonathan H DeLong; Soon Yew Tang; John A Lawson; Ellen Pure; Garret A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

4.  Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine.

Authors:  H Li; J A Lawson; M Reilly; M Adiyaman; S W Hwang; J Rokach; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Simulating obstructive sleep apnea patients' oxygenation characteristics into a mouse model of cyclical intermittent hypoxia.

Authors:  Diane C Lim; Daniel C Brady; Pengse Po; Li Pang Chuang; Laise Marcondes; Emily Y Kim; Brendan T Keenan; Xiaofeng Guo; Greg Maislin; Raymond J Galante; Allan I Pack
Journal:  J Appl Physiol (1985)       Date:  2014-11-26

6.  Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation.

Authors:  B F McAdam; I A Mardini; A Habib; A Burke; J A Lawson; S Kapoor; G A FitzGerald
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 7.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

8.  Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults.

Authors:  Nayyar Iqbal; Serena Cardillo; Sheri Volger; LeAnne T Bloedon; Richard A Anderson; Raymond Boston; Philippe O Szapary
Journal:  Metab Syndr Relat Disord       Date:  2009-04       Impact factor: 1.894

Review 9.  Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry.

Authors:  Clementina Mesaros; Seon Hwa Lee; Ian A Blair
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-17       Impact factor: 3.205

10.  Lipidomic analysis of glycerolipid and cholesteryl ester autooxidation products.

Authors:  Arnis Kuksis; Jukka-Pekka Suomela; Marko Tarvainen; Heikki Kallio
Journal:  Mol Biotechnol       Date:  2009-03-03       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.